Application Nr Approved Date Route Status External Links
ANDA201576 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ropinirole Extended-Release Tablets Are Non-Ergoline Dopamine Agonist Indicated For The Treatment Of Parkinson’s Disease. ( 1) 1.1 Parkinson’s Disease Ropinirole Extended-Release Tablets Are Indicated For The Treatment Of Parkinson’s Disease.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ropinirole Hydrochloride ROPINIROLE HYDROCHLORIDE ZINC2041

Comments